Molecular magnetic resonance imaging of coronary thrombosis and pulmonary emboli with a novel fibrin-targeted contrast agent.
about
Activated platelets in carotid artery thrombosis in mice can be selectively targeted with a radiolabeled single-chain antibodyMultimodality cardiovascular molecular imaging, Part IIMolecular imaging of inflammation in atherosclerosis.Remodeling and homeostasis of the extracellular matrix: implications for fibrotic diseases and cancer.New imaging techniques for diagnosing coronary artery diseaseA contrast agent recognizing activated platelets reveals murine cerebral malaria pathology undetectable by conventional MRIMR imaging probes: design and applications.Design and Control of Nanoconfinement to Achieve Magnetic Resonance Contrast Agents with High Relaxivity.Uncoupling of the profibrotic and hemostatic effects of thrombin in lung fibrosis.Molecular MRI of intracranial thrombus in a rat ischemic stroke model.Targeted probes for cardiovascular MRIIn vivo molecular imaging of thrombosis and thrombolysis using a fibrin-binding positron emission tomographic probe.The role of molecular imaging in diagnosis of deep vein thrombosisFibrin specific peptides derived by phage display: characterization of peptides and conjugates for imagingMagnetic resonance imaging of the coronary arteries.Fibrin-targeted magnetic resonance imaging allows in vivo quantification of thrombus fibrin content and identifies thrombi amenable for thrombolysis.Molecular MRI of Thrombosis.Bimodal thrombus imaging: simultaneous PET/MR imaging with a fibrin-targeted dual PET/MR probe--feasibility study in rat modelFibrin-targeted PET probes for the detection of thrombi.Cardiovascular molecular MR imaging.Molecular imaging of fibrin in a breast cancer xenograft mouse model.Development of contrast agents targeted to macrophage scavenger receptors for MRI of vascular inflammation.Use of cardiovascular magnetic resonance imaging in acute coronary syndromes.Molecular MRI of Atherosclerotic Plaque With Targeted Contrast Agents.Cardiovascular MRI in small animals.Molecular imaging to identify the vulnerable plaque--from basic research to clinical practice.Advances in molecular imaging of atherosclerosis and myocardial infarction: shedding new light on in vivo cardiovascular biology.Nanotechnology in the diagnosis of atherosclerotic disease.Molecular MRI of atherosclerosis.Coronary artery wall imaging.Target binding improves relaxivity in aptamer-gadolinium conjugates.Molecular Cardiovascular Magnetic Resonance: Current Status and Future Prospects.Development of a novel, fibrin-specific PET tracer.Functionalized magnetic resonance contrast agent selectively binds to glycoprotein IIb/IIIa on activated human platelets under flow conditions and is detectable at clinically relevant field strengths.A lysine walk to high relaxivity collagen-targeted MRI contrast agents.An unmet clinical need: The history of thrombus imaging.Molecular magnetic resonance imaging of pulmonary emboli with a fibrin-specific contrast agent.Peptide-based fibrin-targeting probes for thrombus imaging.Dynamic changes in aortic impedance after transcatheter aortic valve replacement and its impact on exploratory outcome.In Vivo MR Imaging of Fibrin in a Neuroblastoma Tumor Model by Means of a Targeting Gd-Containing Peptide.
P2860
Q27348621-1D787FE6-9C3B-49CE-9FBA-5DA3CF963DC3Q30438207-03B0C592-2A31-4F7D-BE19-4AB7A4A3E12BQ30446268-39149445-0CF5-40CE-BD91-9EC27C3EB58EQ30476541-08F04607-6069-456C-A40D-A76DB303B8E7Q30476831-B7C15D9F-BCFF-45E2-BD4A-A1BDF6270C6FQ30481283-95373366-E69F-411F-BB46-ACBE6B34BA11Q30868199-89F6483A-C1EF-44AA-A0CC-3BFCDDD451ECQ31033559-82B4DD05-7361-4EC0-B7B7-DE7D90F72574Q33631115-2F0BEE24-77DF-47B2-9478-83A1DD85866CQ33875934-01E42F24-16EC-4537-BAEE-4B645AAE80EDQ33901726-49DB450F-8092-492A-86B5-9CF639CEBA58Q33916932-C0C8A797-096D-447F-B161-C94E18AFFB2AQ34066512-25969279-FD1E-42E8-B364-B5051D7E46D8Q34134243-BC01ACF0-E885-4C76-A913-9F299D0523D8Q34220060-E6DD188F-5575-48AF-AC8F-07BCF304D376Q34333548-8124710C-641D-4903-B9E1-E09D677B2F17Q34497634-53C7574F-7E5F-4BF8-B221-70BE530B2F0CQ34591066-76BF1C79-5014-4AC1-9331-667ADAE312C5Q36673486-347F32B3-3479-4470-A38F-168141E465E6Q36823807-7B7DE994-D0E0-45E0-80B3-823C0D15E9C8Q36843006-7167306B-0460-43F9-8CEC-171B3DF0C24AQ36914981-BB47F2C0-3F5A-4008-B3AA-0CBA878FFBAEQ37314823-5C0E2825-B85B-4027-9E0B-663E85CAA99EQ37478426-C9AC943F-3501-46DD-8884-51794C29382EQ37656278-911FA6AD-FC32-40E6-BCC5-E5984FA83FF6Q38043973-3EF662A6-3B35-4ED7-88EF-6F9640D8FAC4Q38052020-7EF549A6-E5A5-460F-861B-B72F9C2BB81FQ38089761-6865B08C-7F36-42BF-BA57-87EEB0110A61Q38162728-3B3D7080-7412-4B95-9A7E-2CFF891D91EDQ38258911-9654076C-875D-4CA6-91A9-5355C149213CQ38322510-D96A6B5C-C54A-4CB3-95DC-F0AB2FCE0E23Q38796404-B8680774-F47C-4086-B870-327EABF44B89Q38895099-538C217E-BBD4-4890-86D5-C709E5F5881AQ41871940-938E9066-89FE-4217-AB16-2711EC424166Q45856865-E7C6B5A8-412E-4012-A800-726E7E0461A3Q47177380-68A4A723-7DB3-4884-8F00-56AC4C82E5D3Q47785854-CF0A2B00-3A5D-461E-A246-4B7684B65259Q48625690-E1E5A7D7-BBCC-49E9-BD40-28FB2D60522DQ50639425-DAB5D096-71B1-40E3-85A9-DAFF51E7671AQ50988945-D31E5E9B-35F4-4A90-87B0-450B2DE278F5
P2860
Molecular magnetic resonance imaging of coronary thrombosis and pulmonary emboli with a novel fibrin-targeted contrast agent.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Molecular magnetic resonance i ...... ibrin-targeted contrast agent.
@en
Molecular magnetic resonance i ...... ibrin-targeted contrast agent.
@nl
type
label
Molecular magnetic resonance i ...... ibrin-targeted contrast agent.
@en
Molecular magnetic resonance i ...... ibrin-targeted contrast agent.
@nl
prefLabel
Molecular magnetic resonance i ...... ibrin-targeted contrast agent.
@en
Molecular magnetic resonance i ...... ibrin-targeted contrast agent.
@nl
P2093
P1433
P1476
Molecular magnetic resonance i ...... ibrin-targeted contrast agent.
@en
P2093
Andrea J Wiethoff
Arno Buecker
Edward C Parsons
Elmar Spuentrup
Marcus Katoh
Philip B Graham
Robert M Weisskoff
Rolf W Günther
P304
P356
10.1161/01.CIR.0000158478.29668.9B
P407
P577
2005-02-28T00:00:00Z